Stay updated on Pembrolizumab for Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Metastatic TNBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision marker changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-18T22:49:03.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T23:06:19.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, indicating the study record is temporarily inaccessible. The site chrome (header/footer) remains visible while the 403 message is shown instead of the study details.
    Difference
    19%
    Check dated 2026-09-20T20:35:50.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Added NIH funding disclosure for the study (2015 U.S. NIH Grant/Contract), removed the previous revision text (v3.6.5), and updated the page revision to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-30T17:16:58.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision: v3.6.5 is shown on the page, replacing the previous revision v3.6.4, signaling a minor page or template update. This update does not alter the study details or content presented to users.
    Difference
    0.1%
    Check dated 2026-08-09T07:50:02.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects an update to the page's version or template rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-07-25T17:36:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.